Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I had to go back and look again about the price action on Nasdaq. After the spike on their recent trial results, it came down right away as if the news meant nothing. On the 14th it closed at $6.31. At the open the following morning, precisely the open, it spiked instantly to $6.83 as if it was some manufactured matching of the AIM VRP action already happening. Then it came straight down to spend 3 days in the $5's. As the AIM price began to move higher this week, VRNA followed suit moving back in to the $6's. Sure enough, Tues & Wed saw instant price spikes at the open to $6.75 and $6.91 that once again immediately failed. Now VRNA finds itself back in the $5's once again.
My point is there is a feigned attempt to keep it in line with AIM pricing but it would seem Nasdaq is leading this parade when it should be the bigger funds and $$ in the UK. Somebody needs to step up.
Another thing. I happened to be watching VRNA on Nasdaq yesterday apparently when that hit piece was published. The quick dip brought in a LOT of size buying, or should I sy covering their shorts. Yes, it was organized and paid by someone to get a short position covered. Makes me believe more good news is close at hand.
I brought up the question of who leads the market for ADRs and particularly VRP or VRNA. No one seems to know. But I will say this. Post the recent price run just this past week alone there's been a rather telling phenomenon in the US. On TWO separate occasions, when VRP was up in London, VRNA spiked precisely at the opening bell to $6.90 US. And then instantly down. It was as if to say it was price matching London, now let's get on with continuing to short this thing. And on BOTH occasions, that spike was met with a dip down in to the $5's where we are now. That to me indicates an organized liquidity game to gather shares for something larger to the upside.
As for Weiwei...she's a hack. It's a paid hatchet job. There's no way Wedbush and Suntrust would put out $60 and $34 targets back to back with Wedbush buying a large block if this article were anywhere close to true.